cannabidiol reclassification

The first cannabis medicine, approved by FDA, will target two severe forms of epilepsy. This article from The Washington Post discusses how this may be a step closer to CBD reclassification.
The Food and Drug Administration on Monday approved the first drug derived from marijuana, which will be used to treat two rare and severe forms of childhood epilepsy.
The drug, called ... Continue Reading

A cannabis-derived medicine may soon become the first to be approved by FDA. Then CBD would probably be reclassified by the DEA within 90 days. This article from The Washington Post sheds more light.
At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare ... Continue Reading